Appendix G: New refraction devices

Company	Product/innovation	Commercial status
Essilor (Est. 1972) France	ClickCheck: handheld tube where the patient can look through one end and turn a knob to bring the image into focus. A marking on the side then reports the user’s prescription. Adequate for an initial diagnosis.	Field tested in India and Indonesia. Expected to be commercially available in 2020.
EyeNetra (Est. 2009) Germany	Netra: portable self-test refraction tool powered by a smartphone (fits Samsung S4 only). The user turns a dial to align the patterns and pushes a button to lock them in place. After 8 interactions, the app calculates the difference between what the user sees as “aligned” and the actual alignment of the patterns to provide a prescription.	Clinically validated. Commercially available in 132 countries. Registered with US FDA.
ForusHealth (Est. 2010) India	3nethra aberro: monocular - i.e. each eye is refracted separately - handheld autorefractor using wavefront aberrometry technology. Integrated with a telemedicine platform.	Clinically validated and field-tested in hospitals in India. Available globally. Registered with US FDA.
GV2020 (Est. 2009) US	USee: portable self-refraction device which allows the user to dial lens bars up or down to find the most comfortable correction while viewing a vision chart. The lens bars have a coloured index to indicate the power correction required (+6.00 to -6.00D in steps of 0.25D). Device sold as part of a vision kit for on-the-spot provision of both prescription and reading eyeglasses.	Clinically validated by Johns Hopkins University Hospital study. Field-tested in high schools in Mozambique and rural villages in several countries.
Ovitz (Est. 2012) US	Eyeprofiler: monocular - i.e. each eye is refracted separately - handheld autorefractor using wavefront aberrometry technology.	Clinically validated by 6 tests worldwide. Field testing in South Korea, Bangladesh, and Vietnam. Registered with US FDA.
Plenoptika (Est. 2014) US	QuickSee: binocular - i.e. both eyes refracted at the same time - handheld autorefractor using wavefront aberrometry technology. QuickSee Flip: monocular version of the Quicksee, i.e. each eye is refracted separately, targeting LMICs. Distributed under the ‘e-See’ brand by Aurolab - a subsidy of the Aravind manufacturing company - in India and surrounding countries.	Clinically validated by 1500+ patients across India, US, and Spain. Field tested with Aravind in India. QuickSee and QuickSee flip registered with US FDA and CE marked.
plusoptiX (Est. 2001) Germany	plusoptiX A12R: handheld binocular - i.e. both eyes refracted at the same time - autorefractor designed for babies, children, and uncooperative patients that measures baseline refraction from 1 metre distance in the context of an initial exam. plusoptiX S12R: handheld vision screener that can be used on patients as young as 5 months old. Device takes a picture of the user’s eyes, compares measurement with age-specific thresholds, and displays a “Pass” or “Refer” result.	Clinically validated. Available in 60 countries. Recommended on IAPB Standard List. Registered with US FDA.
Smart Vision labs (Est. 2013) US	SVOne: monocular - i.e. each eye is refracted separately - handheld autorefractor using wavefront aberrometry technology. Integrated with a telemedicine platform.	Clinically validated. Telemedicine feature focused on US market. Registered with US FDA.

Essilor

(Est. 1972)

France

ClickCheck: handheld tube where the patient can look through one end and turn a knob to bring the image into focus. A marking on the side then reports the user’s prescription.

Adequate for an initial diagnosis.

Field tested in India and Indonesia.
Expected to be commercially available in 2020.

EyeNetra

(Est. 2009)

Germany

Netra: portable self-test refraction tool powered by a smartphone (fits Samsung S4 only). The user turns a dial to align the patterns and pushes a button to lock them in place. After 8 interactions, the app calculates the difference between what the user sees as “aligned” and the actual alignment of the patterns to provide a prescription.

Clinically validated.
Commercially available in 132 countries.

Registered with US FDA.

ForusHealth

(Est. 2010)

India

3nethra aberro: monocular - i.e. each eye is refracted separately - handheld autorefractor using wavefront aberrometry technology.

Integrated with a telemedicine platform.

Clinically validated and field-tested in hospitals in India.
Available globally.

Registered with US FDA.

GV2020

(Est. 2009)

USee: portable self-refraction device which allows the user to dial lens bars up or down to find the most comfortable correction while viewing a vision chart. The lens bars have a coloured index to indicate the power correction required (+6.00 to -6.00D in steps of 0.25D).

Device sold as part of a vision kit for on-the-spot provision of both prescription and reading eyeglasses.

Clinically validated by Johns Hopkins University Hospital study.
Field-tested in high schools in Mozambique and rural villages in several countries.

Ovitz

(Est. 2012)

Eyeprofiler: monocular - i.e. each eye is refracted separately - handheld autorefractor using wavefront aberrometry technology.

Clinically validated by 6 tests worldwide.
Field testing in South Korea, Bangladesh, and Vietnam.
Registered with US FDA.

Plenoptika

(Est. 2014)

QuickSee: binocular - i.e. both eyes refracted at the same time - handheld autorefractor using wavefront aberrometry technology.

QuickSee Flip: monocular version of the Quicksee, i.e. each eye is refracted separately, targeting LMICs. Distributed under the ‘e-See’ brand by Aurolab - a subsidy of the Aravind manufacturing company - in India and surrounding countries.

Clinically validated by 1500+ patients across India, US, and Spain.
Field tested with Aravind in India.
QuickSee and QuickSee flip registered with US FDA and CE marked.

plusoptiX

(Est. 2001)

Germany

plusoptiX A12R: handheld binocular - i.e. both eyes refracted at the same time - autorefractor designed for babies, children, and uncooperative patients that measures baseline refraction from 1 metre distance in the context of an initial exam.

plusoptiX S12R: handheld vision screener that can be used on patients as young as 5 months old. Device takes a picture of the user’s eyes, compares measurement with age-specific thresholds, and displays a “Pass” or “Refer” result.

Clinically validated.
Available in 60 countries.
Recommended on IAPB Standard List.
Registered with US FDA.

Smart Vision labs

(Est. 2013)

SVOne: monocular - i.e. each eye is refracted separately - handheld autorefractor using wavefront aberrometry technology.

Integrated with a telemedicine platform.

Clinically validated.

Telemedicine feature focused on US market.
Registered with US FDA.

back cover with the logos of ATscale, the Global Partnership for Assistive Technology; AT2030 and UK aid. This report was delivered under the AT2030 programme funded by UK aid.